EUVIMEDEUVIMED entdecken
Crossref

Vortioxetine improved schizophrenia‐like behavioral deficits in a Poly I:C‐induced maternal immune activation model of schizophrenia in rats

Mehmet Taskiran iD, Sacide Yildiz Taskiran, Gokhan Unal, Nuh Mehmet Bozkurt, Asuman Golgeli

Fundamental & Clinical Pharmacology · 2024

DOI: 10.1111/fcp.13028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Fundamental & Clinical Pharmacology, 2024. Verfasst von Mehmet Taskiran und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Faculty of Science, Erciyes University, Kayseri, Turkey. Hauptthemen laut MEDLINE: Poly I-C, Schizophrenia, Vortioxetine, Disease Models, Animal. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Erciyes University, Erciyes Üniversitesi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Several studies provide clear evidence that exposure to various infections during pregnancy are linked with an increased risk for schizophrenia. In preclinical studies, administration of polyinosinic‐polycytidylic acid (Poly I:C) in pregnant rodents can induce maternal immune activation leading to impairments in brain function in the offspring.

Objectives

The aim of this study was to investigate the effect of vortioxetine, a multimodal selective serotonin reuptake inhibitor (SSRI), in the pathophysiology of Poly I:C‐induced schizophrenia‐like model in rats.

Methods

For this purpose, Poly I:C (8 mg/kg, ip) was injected into pregnant animals 14 days after mating, and tail blood was taken for determination of IL‐6 levels after 2 h. At postnatal days 83–86, behavioral tests were performed.

Results

Our results revealed that Poly I:C caused impairments in prepulse inhibition, novel object recognition, social interaction, and open‐field tests. Chronic administration of vortioxetine (2.5, 5, and 10 mg/kg, ip, postnatal days 69–83) caused significant improvements in these deficits.

Conclusion

Overall, our findings indicate that vortioxetine may provide new therapeutic approaches for the treatment of schizophrenia. We think that increased serotonergic activity in frontal brain regions may provide the ameliorative effect of vortioxetine, especially on negative and cognitive symptoms. Therefore, it will be useful to determine the efficacy of vortioxetine with combined drugs with further studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Poly I-CSchizophreniaVortioxetineDisease Models, AnimalBehavior, AnimalAnimalsFemalePregnancyRatsSelective Serotonin Reuptake InhibitorsPrenatal Exposure Delayed EffectsRats, WistarMalePrepulse InhibitionInterleukin-6

Stichwörter der Autor:innen

Poly I:CSSRImaternal immune activationschizophreniavortioxetine

Substanzen

Poly I-CVortioxetineSelective Serotonin Reuptake InhibitorsInterleukin-6

Autor:innen und Institutionen

  • Department of Biology, Faculty of Science, Erciyes University, Kayseri, Turkey.
  • Department of Physiology, Faculty of Medicine, Erciyes University, Kayseri, Turkey.
  • Department of Pharmacology, Faculty of Pharmacy, Erciyes University, Kayseri, Turkey.

ORCID-Profile: Mehmet Taskiran

Förderung

  • Erciyes University
  • Erciyes Üniversitesi

Zitieren

APA

Taskiran, M., Yildiz Taskiran, S., Unal, G., Bozkurt, N. M., & Golgeli, A. (2024). Vortioxetine improved schizophrenia‐like behavioral deficits in a Poly I:C‐induced maternal immune activation model of schizophrenia in rats. Fundamental & Clinical Pharmacology. https://doi.org/10.1111/fcp.13028

Vancouver

Taskiran M, Yildiz Taskiran S, Unal G, Bozkurt NM, Golgeli A. Vortioxetine improved schizophrenia‐like behavioral deficits in a Poly I:C‐induced maternal immune activation model of schizophrenia in rats. Fundamental & Clinical Pharmacology. 2024. doi:10.1111/fcp.13028

BibTeX
@article{Taskiran2024,
  author = {Taskiran, Mehmet and Yildiz Taskiran, Sacide and Unal, Gokhan and Bozkurt, Nuh Mehmet and Golgeli, Asuman},
  title = {Vortioxetine improved schizophrenia‐like behavioral deficits in a Poly I:C‐induced maternal immune activation model of schizophrenia in rats},
  journal = {Fundamental & Clinical Pharmacology},
  year = {2024},
  doi = {10.1111/fcp.13028}
}
Kostenlos starten →